What is the main business of Monipol Biotech Pl?

The main business activity of Monipol Biotech Pl focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 29, 2024.

Where is the headquarters located?

The headquarters is located at: ul. Retoryka 1, 31-108 Kraków.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of $191,736, representing an increase of 32.9% compared to 2024.

No, the company recorded a net loss of $113,404 in 2025. For comparison, in 2024 the loss was $69,877, meaning the company increased its loss by 61.9%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $151,663 in 2025, representing 52% of all operating expenses.

Monipol Biotech Plsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2024-08-29

Share capital

5,000.00 PLN

Activity description

Monipol Biotech Pl provides CRO services for clinical research in biotechnology, pharmaceuticals and medtech. Operating since 1995, it delivers projects across Europe and supports patient recruitment.

Registered address

ul. Retoryka 1/15, 31-108 Kraków, Poland

Website

monipol-biotech.com

Phone

Social media

Electronic delivery address

AE:PL-41639-70897-JTVBA-12

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 24 days early.

202510/06/2026
202402/07/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 191.74kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD -113.40kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 289.72kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 137.43kMedianUSD 133.19kAverageUSD 3.03m

Industry

Research and experimental development on biotechnology (72.11.Z)Primary
Other research and experimental development on natural sciences and engineering (72.19.Z)
Medical and dental practice activities (86.2)

Offer

Clinical data management
Clinical trial feasibility studies
Clinical project management
Clinical trial monitoring
Regulatory services
Medical writing
Clinical trial start-up

Website technology

Website

WordPress
Elementor

Authorized Representatives

Jan Maláč – President of the Management Board

Manner of representation

Each member of the management board is entitled to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Monipol Clinical Research S.r.o.	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2024-09-06.

mBank
24 1140 1081 0000 4984 1500 1002
mBank
51 1140 1081 0000 4984 1500 1001
mBank
94 1140 1081 0000 4984 1500 1003

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
CTI Clinical Trial and Consulting Services Polandsp. z o.o.	$527,145.56	ctifacts.com
Medicofarma BiotechS.A.	$314,882.33	medicofarmabiotech.pl
MultiqureS.A.	$284,781.52	purebiologics.com
CCTSsp. z o.o.	$281,193.31	ccts.pl
FcbiotechS.A.	$246,877.92	fcbiotech.pl
Frontline BiosciencesS.A.	$219,186.29	frontlinebiosciences.com
TCIsp. z o.o.	$218,471.87	tci.pl
Gcp-Service International Ltd. & Co. KgBranch (foreign co.)	$159,376.34	gcp-service.com
Pharmaxi Polandsp. z o.o.	$152,292.34	pharmaxi.com.ua
Clinbitsp. z o.o.	$114,041.47	clinbit.com